Alsup Trims Drug Co. Investors' Cancer Treatment Study Suit

By Emilie Ruscoe · April 13, 2021, 5:32 PM EDT

A federal judge in San Francisco has trimmed claims from a proposed securities class action accusing biotechnology company Geron Corp. and its chief executive officer of failing to properly explain the...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Tollen v. Geron Corporation et al

Case Number

3:20-cv-00547

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

January 23, 2020